{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:59:47Z","timestamp":1791266387713,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T00:00:00Z","timestamp":1360108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12020-013-9890-5","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T13:58:42Z","timestamp":1360072722000},"page":"411-418","source":"Crossref","is-referenced-by-count":15,"title":["Adiponectin as predictor for diabetes among pre-diabetic groups"],"prefix":"10.1007","volume":"44","author":[{"given":"Hyon-Suk","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Eun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Duk","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kap Bum","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ha","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"key":"9890_CR1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2105\/AJPH.77.12.1549","volume":"77","author":"MG Kovar","year":"1987","unstructured":"M.G. Kovar, M.I. Harris, W.C. Hadden, The scope of diabetes in the United States population. Am J Pub Health 77, 1549\u20131550 (1987)","journal-title":"Am J Pub Health"},{"key":"9890_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","volume":"293","author":"SH Jee","year":"2005","unstructured":"S.H. Jee, H. Ohrr, J.W. Sull, J.E. Yun, J. Min, J.M. Samet, Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293, 194\u2013202 (2005)","journal-title":"JAMA"},{"key":"9890_CR3","doi-asserted-by":"crossref","unstructured":"Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine. (2012). doi: 10.1007\/s12020-012-9830-9 [Epub ahead of print]","DOI":"10.1007\/s12020-012-9830-9"},{"key":"9890_CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.5124\/jkma.2011.54.10.1020","volume":"54","author":"KH Chun","year":"2011","unstructured":"K.H. Chun, Evidence-based management and treatment of high-risk individuals with pre-diabetes. J Korean Med Assoc 54, 1020\u20131027 (2011)","journal-title":"J Korean Med Assoc"},{"key":"9890_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(03)00037-8","volume":"60","author":"KT Chen","year":"2003","unstructured":"K.T. Chen, C.J. Chen, E.W. Gregg, G. Imperatore, K.M. Narayan, Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3\u00a0years. Diabetes Res. Clin. Pract. 60, 177\u2013182 (2003)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"9890_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diab.46.4.701","volume":"46","author":"SL Edelstein","year":"1997","unstructured":"S.L. Edelstein, W.C. Knowler, R.P. Bain, A. Reubin, E.L. Barrett-Connor, G.K. Dowse et al., Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 46, 701\u2013710 (1997)","journal-title":"Diabetes"},{"key":"9890_CR7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.12.7.464","volume":"12","author":"MI Harris","year":"1990","unstructured":"M.I. Harris, Impaired glucose tolerance in the U.S. population. Diabetes Care 12, 464\u2013474 (1990)","journal-title":"Diabetes Care"},{"key":"9890_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00125-007-0893-8","volume":"51","author":"SS Rasmussen","year":"2008","unstructured":"S.S. Rasmussen, C. Gl\u00fcmer, A. Sandbaek, T. Lauritzen, K. Borch-Johnsen et al., Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3\u00a0year follow-up in the ADDITION study, Denmark. Diabetologia 51, 249\u2013257 (2008)","journal-title":"Diabetologia"},{"key":"9890_CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","volume":"302","author":"S Li","year":"2009","unstructured":"S. Li, H.J. Shin, E.L. Ding, R.M. van Dam, Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179\u2013188 (2009)","journal-title":"JAMA"},{"key":"9890_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-149-5-200809020-00005","volume":"149","author":"C Heidemann","year":"2008","unstructured":"C. Heidemann, Q. Sun, R.M. van Dam, J.B. Meigs, C. Zhang, S.S. Tworoger et al., Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med. 149, 307\u2013316 (2008)","journal-title":"Ann. Intern. Med."},{"key":"9890_CR11","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1210\/jc.2010-0716","volume":"95","author":"N Zhu","year":"2010","unstructured":"N. Zhu, J.S. Pankow, C.M. Ballantyne, D. Couper, R.C. Hoogeveen, M. Pereira et al., High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J. Clin. Endocrinol. Metab. 95, 5097\u20135104 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9890_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2337\/dc11-1519","volume":"35","author":"JR Kizer","year":"2012","unstructured":"J.R. Kizer, A.M. Arnold, D. Benkeser, J.H. Ix, L. Djousse, S.J. Zieman et al., Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 35, 415\u2013423 (2012)","journal-title":"Diabetes Care"},{"key":"9890_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/dmrr.2277","volume":"28","author":"Y Li","year":"2012","unstructured":"Y. Li, H. Yatsuya, H. Iso, H. Toyoshima, K. Tamakoshi, Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up. Diabetes Metab Res Rev 28, 349\u2013356 (2012)","journal-title":"Diabetes Metab Res Rev"},{"key":"9890_CR14","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/dc11-2263","volume":"35","author":"AG Tab\u00e1k","year":"2012","unstructured":"A.G. Tab\u00e1k, M. Carstensen, D.R. Witte, E.J. Brunner, M.J. Shipley, M. Jokela et al., Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care 35, 2540\u20132547 (2012)","journal-title":"Diabetes Care"},{"key":"9890_CR15","doi-asserted-by":"crossref","first-page":"e2011007","DOI":"10.4178\/epih\/e2011007","volume":"33","author":"SY Kim","year":"2011","unstructured":"S.Y. Kim, S.J. Lee, H.K. Park, J.E. Yun, M. Lee, J. Sung et al., Adiponectin is associated with impaired fasting glucose in the non-diabetic population. Epidemiol Health 33, e2011007 (2011)","journal-title":"Epidemiol Health"},{"key":"9890_CR16","first-page":"165","volume":"29","author":"SH Jee","year":"2007","unstructured":"S.H. Jee, S. Lee, S. Min, J. Park, H.S. Kim, S.Y. Kim et al., Development of ELISA-kit of quantitative analysis for adiponetin and their correlation with cardiovascular risk factors. Korean J Epidemiol 29, 165\u2013175 (2007)","journal-title":"Korean J Epidemiol"},{"key":"9890_CR17","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.2337\/dc10-0261","volume":"33","author":"SH Jee","year":"2010","unstructured":"S.H. Jee, A.W. Foong, N.W. Hur, J.M. Samet, Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care 33, 2567\u20132572 (2010)","journal-title":"Diabetes Care"},{"key":"9890_CR18","doi-asserted-by":"crossref","unstructured":"H.K. Kim, C.H. Kim, E.H. Kim, S.J. Bae, J. Choe, J.Y. Park, et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: The Korean Heart Study. Diabetes Care. (2012). doi: 10.2337\/dc12-0587 [Epub ahead of print]","DOI":"10.2337\/dc12-0587"},{"key":"9890_CR19","doi-asserted-by":"crossref","unstructured":"O.F. Khabour, S.H. Wehaibi, S.I. Al-Azzam, K.H. Alzoubi, Z.J. El-Akawi. Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect. Clin Exp Hypertens. (2012). doi: 10.3109\/10641963.2012.732645 [Epub ahead of print]","DOI":"10.3109\/10641963.2012.732645"},{"key":"9890_CR20","doi-asserted-by":"crossref","unstructured":"M. Azrad, B.A. Gower, G.R. Hunter, T.R. Nagy. Racial differences in adiponectin and leptin in healthy premenopausal women. Endocrine. (2012). doi: 10.1007\/s12020-012-9797-6 [Epub ahead of print]","DOI":"10.1007\/s12020-012-9797-6"},{"key":"9890_CR21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. 14, 741\u2013751 (2008)","journal-title":"Mol. Med."},{"key":"9890_CR22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","volume":"116","author":"T Kadowaki","year":"2006","unstructured":"T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, K. Tobe, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784\u20131792 (2006)","journal-title":"J Clin Invest"},{"key":"9890_CR23","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.86.5.1930","volume":"86","author":"C Weyer","year":"2001","unstructured":"C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley et al., Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930\u20131935 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9890_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diabetes.52.2.239","volume":"52","author":"O Tschritter","year":"2003","unstructured":"O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe et al., Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52, 239\u2013243 (2003)","journal-title":"Diabetes"},{"key":"9890_CR25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/db06-0506","volume":"56","author":"C Menzaghi","year":"2007","unstructured":"C. Menzaghi, V. Trischitta, A. Doria, Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56, 1198\u20131209 (2007)","journal-title":"Diabetes"},{"key":"9890_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12020-011-9488-8","volume":"40","author":"W Du","year":"2011","unstructured":"W. Du, Q. Li, Y. Lu, X. Yu, X. Ye, Y. Gao et al., Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine 40, 413\u2013422 (2011)","journal-title":"Endocrine"},{"key":"9890_CR27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1373\/49.4.650","volume":"49","author":"T Pischon","year":"2003","unstructured":"T. Pischon, G.S. Hotamisligli, E.B. Rimm, Adiponectin: stability in plasma over 36 hours and within-person variation over 1\u00a0year. Clin. Chem. 49, 650\u2013652 (2003)","journal-title":"Clin. Chem."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-9890-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9890-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:47Z","timestamp":1559440607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-9890-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9890"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-9890-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,6]]}}}